Clal Biotechnology Industries Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Clal Biotechnology Industries Limited with three other
companies in this sector in Israel:
Arcturus Therapeutics Ltd
sales of 46.42 million Israel Shekels [US$12.73 million]
of which 100%
Redhill Biopharma Ltd
(14.31 million Israel Shekels [US$3.92 million]
(12.07 million Israel Shekels [US$3.31 million]
of which 96%
was Agricultural Crops).
Clal Biotechnology Industries Limited reported sales of 54.50 million Israel Shekels (US$14.94 million)
December of 2017.
increase of 118.0%
versus 2016, when the company's sales were 25.01 million Israel Shekels.
Sales of Kayortech saw an increase
that was more than double the company's growth rate: sales were up
669.6% in 2017, from
16.89 million Israel Shekels to 129.97 million Israel Shekels.
Clal Biotechnology Industries Limited also saw significant increases in sales in
Other (up 377.8% to 29.21 million Israel Shekels)
Not all segments of Clal Biotechnology Industries Limited experienced an increase in sales in 2017:
sales of Medivned fell 21.7% to 11.58 million Israel Shekels.